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Abstract
Background: Cancer genomics projects are producing ever-increasing amounts of rich and diverse data from
patient samples. The ability to easily visualize this data in an integrated an intuitive way is currently limited by the
current software available. As a result, users typically must use several different tools to view the different data types
for their cohort, making it difficult to have a simple unified view of their data.
Results: Here we present Cascade, a novel web based tool for the intuitive 3D visualization of RNA-seq data from
cancer genomics experiments. The Cascade viewer allows multiple data types (e.g. mutation, gene expression,
alternative splicing frequency) to be simultaneously displayed, allowing a simplified view of the data in a way that is
tuneable based on user specified parameters. The main webpage of Cascade provides a primary view of user data
which is overlaid onto known biological pathways that are either predefined or added by users. A space-saving menu
for data selection and parameter adjustment allows users to access an underlying MySQL database and customize the
features presented in the main view.
Conclusions: There is currently a pressing need for new software tools to allow researchers to easily explore large
cancer genomics datasets and generate hypotheses. Cascade represents a simple yet intuitive interface for data
visualization that is both scalable and customizable.
Keywords: RNA-seq, Visualization, Cancer genomics, Dimensionality reduction
Background
The growth of next-generation sequencing (NGS) has
revolutionized the study of cancer through the analysis
of data from whole-exome [1] or genome [2, 3] sequen-
cing, the profiling of epigenetic modifications [4] and
transcriptome sequencing (RNA-seq) [5, 6]. RNA-seq is
of particular interest, since it is possible to survey gene
expression, splicing and mutations in a single experi-
ment. Despite these powerful techniques, a growing list
of cancer genomics (CG) studies have demonstrated that
defining the precise genetics of the disease remains chal-
lenging [7, 8]. Since the molecular mechanisms that can
act as “driver events” may differ between patients with
the same type of cancer, it is critical for researchers to
be able to easily integrate the results of RNA-seq ana-
lysis, along with other NGS approaches, to identify
functionally equivalent impacts on conserved biological
pathways. Software tools that allow researchers to
explore their data in an unbiased fashion, to generate
potential hypotheses and that are intuitive enough for
non-bioinformatians (e.g. clinicians) to apply their spe-
cialized knowledge, are therefore critical.
The difficulties associated with the visualization and
exploration of multidimensional cancer genomics data
have been previously discussed [9], along with efforts to
try and address these issues. Ideally, the process of data
exploration would also involve representations that
utilize an intuitive type of “dimensional reduction” (e.g.
with diverse data types being represented by shapes and
colours) in order to display a single coherent summary
of the information. Moreover, such approaches should
also be capable of leveraging the vast amount of verified
biological information stored online in resource data-
bases such as the Molecular Signatures Database
(MSigDB) [10], Pathway Interaction Database (PID) [11],
Reactome [12], and Kyoto Encyclopedia of Genes and
Genomes (KEGG) databases [13].
* Correspondence: brian.wilhelm@umontreal.ca
Laboratory for high throughput genomics, Institute for Research in
Immunology and Cancer, University of Montreal, Montreal, QC, Canada
© 2016 Shifman et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shifman et al. BMC Genomics  (2016) 17:75 
DOI 10.1186/s12864-016-2389-8
Here we present Cascade, a new data visualization tool
to display and explore NGS datasets in a rapid and intui-
tive way by allowing multiple data attributes to be shown
simultaneously. Cascade allows the analysis of RNA-seq
data, or whole-exome or genome sequencing, to be eas-
ily mapped onto known or user defined biological path-
ways. The program uses a variety of tunable parameters
to highlight specific attributes of genes/features that are
of interest to the researcher. Cascade can also easily in-
tegrate other data sources and, through user configur-
able gene lists and networks, highlight relevant features
of the data. By allowing researchers and clinicians with
specialized information to browse and explore their data
in the context of existing biological knowledge, Cascade
fills a gap which currently exists between tools used ini-
tially to process the data for highly specific tasks (read-
mapping, variant detection) and tools that allow reanaly-
sis of published data.
Implementation
Cascade is a web-based user interface that allows re-
searchers to interactively explore their RNA-seq data
while allowing a wide variety of data types to be dis-
played. Cascade consists of the main web page, an
underlying relational database (MySQL) containing all of
the information from RNA-Seq experiments (along with
information defined in biological pathways, gene lists,
etc.) and a collection of PHP scripts allowing the user to
submit requests to the database to be displayed in the
browser (Fig. 1).
The main Cascade webpage uses the scripts from the
Java library Three.JS [14] to generate interactive 3D
forms without a requirement for specific browser plu-
gins. The main page is sub-divided into a plotting canvas
where the genes (nodes) and interactions (edges) are
rendered, a space-saving, collapsible, menu on the left-
hand side of the application [15] and a fixed information
ribbon at the top of the page (Fig. 2). The rendering can-
vas depicts genes as spheres on a single plane linked by
edges/lines (interactions) with concentric rings as an ar-
bitrary guide for pathway depth (which can be toggled
on/off ). Gene names are shown above each node and
gene expression values are represented as green vertical
lines. The functionality of Three.JS is completely generic
and therefore although the planar view is a default rep-
resentation (since many established pathways have a se-
quential order of interactions), the Cascade source code
could be modified to also allow the representation of
typical “hair-ball” network diagrams. Cascade graphics
are also entirely customizable by end-users and some
modifications (e.g. colour selection, font size) can be
made directly through a simple file of parameters.
In order to optimize the use of screen space, a collaps-
ible side-menu (Fig. 2) to view the data selection options
is displayed on the left side of the page. The menu al-
lows users to alter 4 aspects of the rendered view: A) the
data types to include in the representation, B) the bio-
logical pathway to overlay data onto, C) the source of
the RNA-seq data, and D) the gene list selection to re-
strict frequency colouring for the data types selected.
The choice of data types to represent is dependent only
on what is available in the database or uploaded by the
user, allowing individuals to tailor the view to their
needs. Although Cascade could easily be altered to dis-
play any type of data (gene lengths, %GC, etc.), has been
designed for cancer genomics data. Therefore the default
data types available to be shown (if available) are copy
number variations (CNVs), single nucleotide variants
(SNVs; either novel or known damaging variants), gene
expression (either mean/median levels of gene transcrip-
tion), alternate splicing, and insertion/deletions (indels).
For instance, activating the “alternative splicing” option
will add coloured rings around nodes based on whether
or not that gene has been flagged by the user as exhibit-
ing alternative splicing. User supplied values are required
for this which could represent a binary observation of al-
ternative splicing or a skewed ratio of isoforms since in-
dividual isoforms cannot be represented. Likewise, the
Fig. 1 Overview of Cascade organization. A cartoon view of Cascade is shown with the three principal components coloured. The relational
database (blue) holds all user defined data (e.g. from RNA-seq experiments) along with pre-defined data for biological pathways, networks, disease
associated genes, etc. A collection of Java/PHP scripts (pink) act as bridge between the database and the main webpage (grey) used for user
interaction and data visualization
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presence of known/predicted deleterious SNVs must be
assigned by the user when the data is loaded into the
database in order for it to be displayed properly and for
cohort frequencies to be calculated properly. The second
input required form the user is to define the biological
pathway to overlay the RNA-seq data onto. A number of
predefined pathways from KEGG have been entered and
Cascade will also accept user-generated files of pathways.
A text search box in the upper right allows restriction of
shown pathways based on gene name or function title.
In order to allow rapid browsing of RNA-seq data in
multiple pathways Cascade also allows for a “quick-
scroll”. This can be accomplished by left clicking on the
left/right arrows next to the current pathway name or by
a right mouse button click-drag anywhere on the screen.
A click-drag change in horizontal position of more than
200 pixels (similar to a “swipe” gesture on a smart
phone) will trigger the transition from the current path-
way to the next (either before or after, depending on the
click-drag direction). The third user option on the menu
is the RNA-seq data source which can be selected simply
by clicking on the appropriate box in the section, with
the current data source shown highlighted in green.
Lastly, the fourth option, which is to restrict the colour
frequency displays to specific genes, can be activated by
clicking on a specific gene list. Because the inclusion of
novel SNVs in a large cohort can have the effect of
“swamping” the view with coloured nodes, the gene list
restriction allows users to restrict the colouring to only a
specific list of genes (independent of which pathway is
being examined). Several default lists of genes implicated
with specific diseases are provided, but users can enter
their own gene list using the “Select File” option below
the lists. Gene lists can also be selected based on the
presence of specific genes names through the textbox
search tool similar to the pathway list.
Cascade is designed to calculate and summarize fea-
ture information from a cohort of samples in the ren-
dered network view through a node/shape colouring
scheme. When an experimental data source is selected
from the side menu, the data is loaded from the database
and client side calculations are performed to generate
statistics, including gene expression distribution (mean,
median), and mutation/alternative splicing frequencies.
The resulting statistics are then used to alter the colour/
rendering of the nodes within the current network based
on the user-defined parameter values. For frequency
based values, the data is partitioned into three bins using
user defined limits and a gradient color scheme. This al-
lows users to differentiate between mutations which are
rare/absent (“low” in white), infrequent (“intermediate”
in pink) and common (“high” in red) and highlight
changes which are of most interest. The numerical limits
of the three bins can be altered by selecting the “modify
ranges” button at the top of the page in the fixed infor-
mation ribbon. Because these cohort-based calculations
are performed on the client side, large cohorts/networks
(>200 samples) can result in somewhat slower rendering
Fig. 2 Screenshot of data rendering on main webpage. Cascade uses a space-saving menu on the left-hand side of the screen to store functions
to: (a) select features of the RNA-seq data to be displayed, (b) select biological pathways to overlay data onto, (c) select datasets to use for
visualization of features selected (using a) and (d) restrict the colouring thresholds for features based on custom or predefined disease gene lists.
The “modify ranges” button (top centre) allows users to alter the cohort frequency thresholds (a) required for node colour changes (mutations) or
ring appearance (splicing). Additional buttons (top) toggle display of guide rings, generate (.jpg) screen images or open tool documentation
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times and therefore should be performed on relatively
modern workstation (e.g. >8GB RAM, and a discrete
graphics card) running any up-to-date browser which
supports WebGL.
In order to allow the user to control the complexity of
the pathway view, Cascade also has the capability of ren-
dering gene families, such as the Janus kinase family
(JAK1, JAK2, JAK3, and TYK2) for instance, as a single
(brown) node. These family nodes do not show data
values by default, but they can be expanded by left-
clicking on the node which then plots the child nodes
within the family above the plane of the network with
their respective colouring and information (Fig. 3). Once
a gene of interest has been identified, left clicking the
node will open a new vertically tabbed window. The de-
fault “About” tab contains gene information that is dy-
namically retrieved from RefSeq entries provided the
proper HUGO gene symbol is used in the pathway. Add-
itional tabs allow more detailed views of expression pat-
terns, mutation/SNP presence, alternative splicing and
copy number variations (CNVs) on a per sample basis.
PHP Scripts
The server-side components of Cascade are run on an
Apache web server supporting PHP, while the back-end
scripts act as an interface between the client and the ser-
ver. The server-side scripts used by Cascade belong to
two categories, either server retrieval or server storage.
The scripts for data retrieval return one of the pre-
existing pathways from the database, including the genes
within the network, their connections, and the keyword
descriptions of the pathway. Additional retrieval scripts
can return detailed sample information based on the
gene name, in addition to lists of genes associated with
specific diseases. In order to allow greater flexibility for
users, Cascade is currently designed to save novel, user-
defined, pathways (added via a file upload) to the server
directly from the main webpage. This option transfers
the pathway information (genes, connections, pathway
category) to the server, making it available for use by
other users. Other user-defined information (additional
genes, expression data, etc.) can be added to the data-
base but this requires direct access (e.g. using MySQL
Workbench, MySQL plugin for excel) rather than
through using the webpage.
JavaScripts
Cascade is built using the Three.JS framework (3JS), a
Javascript library designed to provide fast, efficient three
dimensional web rendering functionality for the user
interface. In order to render a 3D scene, 3JS requires
three elements: a camera, a model, and a light source.
Because 3JS allows generic and abstract visualization,
the model used by Cascade is an interconnected gene
network and is defined through a series of 3D vectors
and shapes. Each shape in the view has an associated
material and attributes (referred to as “optical proper-
ties”) that define how it is rendered. These properties
can be used by Cascade to define elements of interest
(e.g. through colour changes) based on user-defined cri-
teria. The “camera” in Cascade represents a mathemat-
ical operation defining the perspective view of the
Fig. 3 Visualization of gene families. In order to reduce the complexity of the gene view in Cascade, families of closely related genes can be
represented by single nodes in the main rendering view and expanded by left clicking on the “parent” node. The child nodes are then shown,
with appropriate colouring and information according to the user thresholds, on a second elevated plane. Left-clicking on these child nodes
reveals the same tabbed window for individual genes as on the main plane
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model. The view in Cascade is defined by several dis-
tance parameters that allow the perspective to be dy-
namically recalculated as the user pans or zooms within
the view. Within the Cascade view, light sources have
been added to create an even level of illumination re-
gardless of the 3D perspective, making it easier to see
the colours applied to shapes.
Database
The Cascade demonstration website uses a mySQL rela-
tional database with an InnoDB transaction model,
allowing foreign key constraints on the database and by
extension, each pathway. Tables with pathway informa-
tion are linked by a series of cascading index keys which
allows for more efficient information retrieval. Cascade
queries are sent to the server to retrieve a pathway
through the pathway table, allowing the subsequent re-
trieval of the complete network sequence for rendering
(Additional file 1: Figure S1).
All user-supplied biological data is also stored in the
database with each data type (mutations, expression,
CNVs and alternate splicing data) in separate tables and
linked by unique sample identifiers. When Cascade per-
forms a server call for data, the server receives a list of
genes and samples based on the pathway and data
source selected, and returns the corresponding data, if
available, for calculation and rendering. Cascade does
not require all data types to be available in order to
visualize the existing data. On the other hand Cascade
does not evaluate the nature of the data that is assigned
to each pre-defined category. In principle, this allows ex-
tensive user driven customization through very minor al-
terations in the HTML code, for instance replacing
“alternative splicing” with “promoter methylation”. Aside
from a mandatory sample identifier (e.g. patient num-
ber), the format of each table is simply defined by the
data type stored: binary values (e.g. 1/0, true/false) for
mutations and alternate splicing, or a numeric value
(e.g. 2, 3.8) for CNVs and expression.
In order to facilitate the identification of subgroups
within data, expression values are evaluated for devia-
tions from the sample means (through user adjustable
values in the source code), such that genes which con-
tain at least a certain percentage of outlier samples will
be indicated by a red expression value at the top of the
vertical line (typically RPKM values (Reads Per Kilobase
of transcript per Million mapped), but any numeric ex-
pression values could be used with minor adjustments).
Similarly, user-supplied alternate splicing values for
genes are represented as a ring around the gene node
(Fig. 4), with coloring reflecting the frequency of splicing
in the same way as mutation frequency. Lastly, copy
number variations (CNVs) are represented as gene nodes
that are positioned above or below the plane, depending
Fig. 4 Screenshot of CNV and splicing representation. Copy number variations (CNVs) are represented in the Cascade display as gene nodes
raised or lowered from the plane of the pathway by a height which is proportional to the value of the average CNV value within the samples
set. Copy number gains are shown as nodes onto top of red cones, which copy losses as shown as genes on green cones. Alternative splicing
frequency within a sample cohort is represented by a ring around the node which is coloured according to the frequency thresholds defined
by the user
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on whether there are copies gained (above) or lost
(below), on average, in the data set (Fig. 4). CNVs can ei-
ther be displayed as Boolean values (constant +/−), or in
relative values where the node deviation represents the
mean CNV value, through multiple clicks on the CNV
button.
Results
The current web-accessible version of Cascade contains
published cancer genomics data from either ALL (Leu-
cegene [16]), AML or prostate (TCGA [7, 8]) RNA-seq
studies as well as demonstration data used to highlight
functionality of the software. While the data currently
accessible from Cascade provides the basis for visualiz-
ing different aspects of RNA-seq experiments, the nature
of how the data is treated is quite flexible. For instance,
in the demonstration data, the CNV option currently
presents an average of the store values for each gene. Be-
cause the values in actual sample data may represent a
more homogenous group with a few outliers (amplifica-
tions), this display mechanism may not be ideal, since
the average CNV within the cohort might produce only
a small elevation which could mask relevant differences.
A simple alternative is to simply use a frequency thresh-
old (as for mutations) where a cone of non-meaningful
height is added as a flag to highlight genes that pass this
threshold. Users can then click on specific gene nodes to
examine the CNV data under the specific tab for specific
targets of interest. Therefore, while Cascade is current a
functional stand-alone tool, various aspects of its func-
tionality can tailor the output to suit the needs of indi-
vidual research labs.
Use case for T-ALL
In order to assess the usefulness of Cascade for cancer
genomics data exploration we generated a number of
biological pathways based on KEGG information and
also entered a number of published RNA-seq datasets
into the Cascade database. As an initial confirmation of
function, we examined a previously published analysis of
ovarian cancer data by Zhengyan et al. [17]. In this paper
the somatic mutations present in 441 tumors from 4 tis-
sues were examined and MAP2K4 (involved in JNK sig-
nalling) was characterized in more detail. Using a
pseudo-cohort of patient data with equivalent frequen-
cies for the CNV changes and mutations, along with a
generic RTK pathway, the view in Cascade clearly
showed copy number increases of oncogenes and losses
of tumor-suppressors, along with a higher frequency of
mutations in a number of the genes in the pathway
(Fig. 5). This demonstration provides a simple example
of how Cascade can present an integrated view of vari-
ous data types.
We next re-examined human T-ALL data published
recently [16] to look for novel insights using Cascade. In
the original publication, the leukemogenic role of CNVs
and mutations in CDKN2A and NOTCH1 were respect-
ively examined. To complement the expression and mu-
tation data for these samples, we also added data for
alternative splicing (generated using MISO [18]) to the
dataset in Cascade. We then generated pathways based
on KEGG interactions along with recent publications for
NOTCH signalling [19, 20] (Fig. 6) since mutations in
the NOTCH1 gene essentially divide the dataset in two.
In examining the view of the Notch pathways, we ob-
served that the expression of NOTCH3 was highlighted
as containing outliers (along with PAWR). While PAWR
and THAP1 have been implicated in the alternative spli-
cing of CCAR1 [20] (which Cascade shows occurs a low
frequency with default settings), the correlation of
NOTCH3 expression levels with other anomalies has not
been specifically investigated in cohorts of T-ALL pa-
tients. Using Cascade’s “gene expression” tabs for the
NOTCH3 and PAWR nodes reveals a highly dichotom-
ous expression pattern for the same sets of patients.
Interestingly, expanding the CNV tab for the previously
Fig. 5 An example use-case of Cascade. A representation of the biological pathway for MAP2K4 published by Zhengyan et al. is shown with CNV
and mutation data adapted from the analysis of ovarian cancers. The increased frequency of CNV gains in oncogenes (e.g. AKT, PI3K, RAF) and loss
in tumor suppressors (e.g. NF1, PTEN) are evident while mutations in oncogenes and tumor suppressors (red nodes) are also displayed
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published CDKN2A copy number loss and sorting on
the relative copy number shows that the patient samples
with a copy loss of CDKN2A also have higher expression
of NOTCH3 and PAWR. Although other pathway
members (e.g. NOTCH1, MDM2) do not change in ex-
pression as a result of the CDKN2A CNV, other genes
highlighted with outliers (e.g. LATS2, FLT3) show the re-
verse pattern (also shown in Fig. 7). These consistent
Fig. 6 Notch signalling in Cascade. A NOTCH signalling pathway was designed and loaded into Cascade and previously published T-ALL data
\was overlaid on to the pathway. Thresholds for mutations and splicing were left at default values and visualizing of splicing and CNVs
was activated
Fig. 7 Gene expression differences based on CDKN2A loss. Boxplots of the expression level (log RPKM) of 7 genes implicated in NOTCH signalling
are shown, with individual patient RPKM values being shown as dots. For the expression of all genes, patients were grouped based on their copy
number loss of CDKN2A (first column) which ablates gene expression. In cases where differences were observed, the significance (based on a
Welch two sample t-test) is shown (ns = not significant, * = p < 0.05, ** = p < 0.01)
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differences suggest that there is a specific biological re-
sponse in T-ALL samples with NOTCH1 mutations and
loss of CDKN2A that potentially involves enhanced
NOTCH3 expression. This has previously been suggested
to be important for T-ALL, but not in combination with
genetic anomalies in NOTCH1 and CDKN2A [19]. The
higher expression levels of other signalling proteins (e.g.
FLT3) seen in NOTCH1 wt patients suggests that in
these patients, alternative pathways for activation may
be critical. It is also of interest to note that MAML3
shows alternative splicing in 2 samples (both of which
lack the CDKN2A CNV) since the altering splicing of
MAML factors has been found to impact NOTCH sig-
nalling in flies [21]. Taken together, the observations in
Cascade using an integrated view of gene expression,
splicing, CNVs and mutations highlight several potential
novel connections related to T-ALL signalling through
the NOTCH pathway. While other views of this signal-
ling pathway or network can be generated (Fig. 8), they
lack the ability to integrate and represent all of the data
as Cascade does, making it far less likely that observa-
tions above would have been clearly evident.
Discussion
Cancer genomics RNA-seq experiments, along with
whole genome/exome sequencing, have rapidly evolved
into standard methodologies for the characterisation of
tumors in both clinical and research contexts. This has
resulted in the rapid proliferation of bioinformatics tools
to optimize read mapping (reviewed in [22]), mutation/
variant detection (reviewed in [23]) and identification of
chromosomal fusions [24]. Despite this, the interpret-
ation of cancer genomics data for large cohorts still rep-
resents an unresolved challenge for researchers looking
for common genetic mechanisms in the disease. Further-
more, while a wide range of more targeted software has
developed for earlier analytical stages, there has been
significantly less emphasis on tools for integrated
visualization of the resulting data.
Currently, there are a number of tools available to
visualize specific aspects of the data (reviewed in more
detail elsewhere [9, 25]), which can be broadly grouped
into three classes: track based viewers, network based
viewers, or data analysis/retrieval portals. Track based
tools such as IGV [26], UCSC genome browser [27],
GBrowse [28], Ensembl [29], and Artemis [30] allow for
the visualization of read mapping coverage and muta-
tions, and continuous value characteristics (e.g. enrich-
ment data for ChIP-seq, DNA methylation, chromatin
accessibility, etc.). Track-based viewers are generally
most useful for the visualization of individual genes or
loci (e.g. to validate mutations), in order to simultan-
eously view several data types (e.g. gene expression data
with ChIP-Seq data). While useful for specific
applications, the ability to view large numbers of sam-
ples or data types (while maintaining all samples in a
single view) is practically limited by the screen space
available for representation of tracks. Network based
data visualization tools such as Cytoscape [31] or Gene-
mania [32] alternatively allow users to generate a generic
two-dimensional (or three dimensional with BioLayout
Express 3D [33]) representation of interactions (e.g. gen-
etic or protein) shown as nodes connected by edges.
These tools offer more flexibility with respect to the way
in which the data is organized and represented and can
typically overlay gene expression data. In spite of this,
because the primary use of these programs was not to
simultaneously represent the full range of RNA-seq data
types, their functionality can impose limits on how the
data can be analyzed. Lastly, other dedicated CG analysis
tools such as cBioportal [34] and the UCSC Cancer Gen-
ome [35] browser offer data visualization services along
with a number of integrated analysis tools. This ap-
proach permits researchers to examine already published
patient cohorts although both tools are largely “gene-
centric” and require the user to enter specific gene
names in order to examine these specifically. Other can-
cer genomics data portals such as the TCGA cancer gen-
omics hub (https://cghub.ucsc.edu/) or visualization
tools such as Mapman (http://mapman.gabipd.org/web/
guest/home), or Gittools (http://www.gitools.org/) also
address some specific concerns but do not represent
generic solutions for visualization. Overall, while all of
the software described above can be useful for cancer
genomics, tools that allow data exploration and hypoth-
esis generation from unpublished data are still lacking.
We have developed Cascade as novel tool to address
this need and aid researchers with the exploration of
their RNA-seq data. Cascade is designed to allow a sort
of “dimensionality reduction” of a data set (e.g. one view
to represent 4–5 data types) while still allowing users to
easily access the underlying data for each sample. This
ability is critical, since presenting an average gene ex-
pression value for a particular gene could, for instance,
hide a bimodal distribution pattern of expression values.
Although the importance and utility of data
visualization for large datasets is clear, there has historic-
ally been a very strong bias against using three dimen-
sional approaches to do this [36]. Two of the principle
arguments against the use of 3D approach (for data that
is not inherently structural, such as protein crystal struc-
tures) are the occlusion of objects in the field of view
and visual misrepresentation of data due to differences
caused by a 3D perspective projected in 2D. Although
such problems can be highly problematic in static 3D
views, in Cascade the view can be easily rotated and
zoomed and therefore this problem is largely obviated.
Indeed, a rotatable or dynamic view has been suggested
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Fig. 8 (See legend on next page.)
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to address exactly this problem [36]. The problem of ap-
parent size differences created by the view perspective is
however inherent in any 3D viewer. Therefore, Cascade
displays in addition to the vertical bars numerical RPKM
values to remove potential perspective based problems.
In addition, no other object in Cascade uses size -encod-
ing to represent data. One last concern with 3D visuali-
zations relates to colours, shading and lighting that can
be influenced by “shadows” cast by objects in the view.
Because the node sizes used by Cascade are small and
relatively distant and the view has uniform and multidir-
ectional lighting, the colour-encoded data is clearly vis-
ible. In summary, Cascade was designed specifically to
avoid many of the main concerns of 3D data
visualization tools.
Through our use case for T-ALL, we show that Cascade
can help to address this need and while the potential hy-
potheses generated (NOTCH3 activation being linked to
NOTCH1 /CDKN2A loss, alternative activation of FLT3
along with a potential role for alternative splicing of
MAML members in NOTCH1 wt patients) would require
experimental validation, the goal of Cascade is simply to
allow users to rapidly generate novel hypotheses based on
their data. Given the incredible volumes of complex can-
cer genomics data being generated, it is increasing critical
that researchers have access to such simple and intuitive
tools to explore their data in an unbiased fashion. The use
case presented above also reflects the importance of being
able to leverage existing knowledge (e.g. biological path-
ways, interactions, etc.) to be able to uncover novel bio-
logical relationships. Although no single tool will reveal
the biology of cancer, Cascade allows users to tailor the
view of their data, making it simpler to focus on specific
combinations of biological phenomena (expression and
splicing, CNV and expression, mutations and splicing,
etc.) which may be relevant.
While the primary goal for the development of Cas-
cade was to provide an intuitive interface for visualizing
data, it also allows end-users considerable flexibility to
customize the view to suit their data as discussed above.
Therefore while a number of common data types are de-
signed into the Cascade viewer, the data type repre-
sented (including the HTML labels shown in Cascade)
can easily be altered, providing a more generic and
customizable tool. Since the Three.JS library can present
any type of shape, material, lighting, etc. the basic frame-
work of Cascade could easily be extended to include
additional information regarding regulatory relationships
(e.g. along edges) or additional forms of data (e.g. DNA
methylation). Additionally, the interface can easily be
modified to display data from other organisms (e.g. bac-
teria, plants, etc.) or for other experiment types (e.g.
metabolomics) with appropriate user-supplied annota-
tion. By hosting the Cascade code within a central re-
pository, the expectation is that this will facilitate the
incorporation of new functionality into the standard re-
lease versions.
Conclusions
As an ever-increasing amount of data from cancer gen-
omics projects becomes available, the development of
tools to allow the exploration of this data is becoming a
critical priority. Cascade is a novel tool for the
visualization of RNA-seq data from cancer genomics
projects, which has the advantages of providing re-
searchers with an intuitive interface for exploring their
data in the context of known biological pathways. In
addition, Cascade is designed to be easily customized
with respect to both the data and the display, ensuring
that atypical data types can be represented with the Cas-
cade framework. The planned continued development of
Cascade will add functionality for analysis and compari-
son of datasets, allowing researchers and clinicians to




Project home page: http://bioinfo.iric.ca/~shifmana/
Cascade/
Source code: https: https://github.com/aaronshifman/
Cascade_RNAseq_viewer
Operating system(s): Web based, Platform independent.
Programming language: HTML5: HTML + CSS +
JavaScript
Other requirements: modern browser (2012+), 2Gb
RAM
License: GPL2
Any restrictions to use by non-academics: None
Ethics
No ethics approval was required for the use of the clin-
ical data used in this study.
(See figure on previous page.)
Fig. 8 Alternative NOTCH pathway representations. NOTCH signalling pathways are shown that were either pre-defined through manual curation
of literature (a – from KEGG) or generated dynamically through known genetic and physical interactions along with other molecular properties
(b – from GeneMania). The interaction network defined by GeneMania was saved an imported into Cytoscape (c - ver.3.2.1) and T-ALL patient
RPKM values were used to colour nodes based on high/medium/low (red/grey/black) expression level
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Additional file
Additional file 1: Figure S1. Cascade database schema. The database
schema for Cascade is shown with boxes differentiating the three
principle data types. The tables in part A represent the user supplied
RNA-seq results including gene expression, mutation status, CNVs and
alternative splicing. The tables in section B represent annotation files for
genes and transcripts in addition to insertions and deletions (Indels) and
single nucleotide polymorphisms (SNPs) and their consequences. The last
section (C) contains tables with information for predefined or custom
biological pathways, the genes involved in the pathways, pathway
annotation as well as disease associated gene lists. (PDF 1149 kb)
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ALL: T-cell acute lymphoblastic leukemia; wt: Wild-type.
Competing interests
The authors declare they have no competing interests.
Author’s contributions
ARS developed/documented the software with input from BTW. ARS, RJ and
BTW wrote the paper and participated in revisions. All authors read and
approved the final manuscript.
Acknowledgements
The authors would like to acknowledge Dr. Chris Maher (Wash U) and Dr
Toby Sargeant (WEHI) for providing feedback used for improving aspects of
the functionality of Cascade. We would also like to thank other members of
the lab and Josette-Renée Landry for assistance with editing the text of the
manuscript. This work was supported by funding from the Cole Foundation
(BTW), the Cancer Research Society (BTW), The Natural Sciences and
Engineering Research Council of Canada (BTW), and Genome Canada (BTW).
Received: 22 September 2015 Accepted: 11 January 2016
References
1. Stark MS, Woods SL, Gartside MG, Bonazzi VF, Dutton-Regester K, Aoude LG,
et al. Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic
melanoma identified by exome sequencing. Nat Genet. 2011;44(2):165–9.
2. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, et al. DNA
sequencing of a cytogenetically normal acute myeloid leukaemia genome.
Nature. 2008;456(7218):66–72.
3. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al.
Recurring mutations found by sequencing an acute myeloid leukemia
genome. N Engl J Med. 2009;361(11):1058–66.
4. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al.
DNMT3A mutations in acute myeloid leukemia. N Engl J Med.
2010;363(25):2424–33.
5. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for
transcriptomics. Nat Rev Genet. 2009;10(1):57–63.
6. Wilhelm BT, Landry JR. RNA-Seq-quantitative measurement of expression
through massively parallel RNA-sequencing. Methods. 2009;48(3):249–57.
7. Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian
carcinoma. Nature. 2011;474(7353):609–15.
8. Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of
adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059–74.
9. Schroeder MP, Gonzalez-Perez A, Lopez-Bigas N. Visualizing
multidimensional cancer genomics data. Genome Med. 2013;5(1):9.
10. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA,
et al. Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A.
2005;102(43):15545–50.
11. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, et al. PID: the
Pathway Interaction Database. Nucleic Acids Res. 2009;37(Database issue):
D674–679.
12. Croft D, O’Kelly G, Wu G, Haw R, Gillespie M, Matthews L, et al. Reactome: a
database of reactions, pathways and biological processes. Nucleic Acids Res.
2011;39(Database issue):D691–697.
13. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 2000;28(1):27–30.
14. Three.js [http://threejs.org/]
15. Takeda A, Goolsby C, Yaseen NR. NUP98-HOXA9 induces long-term
proliferation and blocks differentiation of primary human CD34+
hematopoietic cells. Cancer Res. 2006;66(13):6628–37.
16. Simon C, Chagraoui J, Krosl J, Gendron P, Wilhelm B, Lemieux S, et al. A key
role for EZH2 and associated genes in mouse and human adult T-cell acute
leukemia. Genes Dev. 2012;26(7):651–6.
17. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, et al. Diverse
somatic mutation patterns and pathway alterations in human cancers.
Nature. 2010;466(7308):869–73.
18. Katz Y, Wang ET, Airoldi EM, Burge CB. Analysis and design of RNA
sequencing experiments for identifying isoform regulation. Nat Methods.
2010;7(12):1009–15.
19. Pelullo M, Quaranta R, Talora C, Checquolo S, Cialfi S, Felli MP, et al. Notch3/
Jagged1 circuitry reinforces notch signaling and sustains T-ALL. Neoplasia.
2014;16(12):1007–17.
20. Lu C, Li JY, Ge Z, Zhang L, Zhou GP. Par-4/THAP1 complex and Notch3
competitively regulated pre-mRNA splicing of CCAR1 and affected inversely
the survival of T-cell acute lymphoblastic leukemia cells. Oncogene. 2013;
32(50):5602–13.
21. Giraldez AJ, Perez L, Cohen SM. A naturally occurring alternative product of
the mastermind locus that represses notch signalling. Mech Dev. 2002;
115(1–2):101–5.
22. Fonseca NA, Rung J, Brazma A, Marioni JC. Tools for mapping high-
throughput sequencing data. Bioinformatics. 2012;28(24):3169–77.
23. Farrer RA, Henk DA, MacLean D, Studholme DJ, Fisher MC. Using false
discovery rates to benchmark SNP-callers in next-generation sequencing
projects. Sci Rep. 2013;3:1512.
24. Fernandez-Cuesta L, Sun R, Menon R, George J, Lorenz S, Meza-Zepeda LA,
et al. Identification of novel fusion genes in lung cancer using breakpoint
assembly of transcriptome sequencing data. Genome Biol. 2015;16:7.
25. Pavlopoulos GA, Malliarakis D, Papanikolaou N, Theodosiou T, Enright AJ,
Iliopoulos I. Visualizing genome and systems biology: technologies, tools,
implementation techniques and trends, past, present and future. Giga
Science. 2015;4:38.
26. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G,
et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24–6.
27. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The
human genome browser at UCSC. Genome Res. 2002;12(6):996–1006.
28. Donlin MJ. Using the Generic Genome Browser (GBrowse). Current protocols
in bioinformatics / editoral board, Andreas D Baxevanis [et al.] 2007, Chapter
9:Unit 9 9.
29. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, et al. The
Ensembl genome database project. Nucleic Acids Res. 2002;30(1):38–41.
30. Carver T, Harris SR, Berriman M, Parkhill J, McQuillan JA. Artemis: an
integrated platform for visualization and analysis of high-throughput
sequence-based experimental data. Bioinformatics. 2012;28(4):464–9.
31. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al.
Cytoscape: a software environment for integrated models of biomolecular
interaction networks. Genome Res. 2003;13(11):2498–504.
32. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al.
The GeneMANIA prediction server: biological network integration for gene
prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web
Server issue):W214–220.
33. Enright AJ, Ouzounis CA. BioLayout–an automatic graph layout algorithm
for similarity visualization. Bioinformatics. 2001;17(9):853–4.
34. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio
cancer genomics portal: an open platform for exploring multidimensional
cancer genomics data. Can Dis. 2012;2(5):401–4.
35. Cline MS, Craft B, Swatloski T, Goldman M, Ma S, Haussler D, et al. Exploring
TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser. Sci Rep.
2013;3:2652.
36. Gehlenborg N, Wong B. Into the third dimension. Nat Methods.
2012;9(9):851.
Shifman et al. BMC Genomics  (2016) 17:75 Page 11 of 11
